7.77
+0.18(+2.37%)
Currency In USD
| Previous Close | 7.59 |
| Open | 7.77 |
| Day High | 7.77 |
| Day Low | 7.77 |
| 52-Week High | 10 |
| 52-Week Low | 6.55 |
| Volume | 18,341 |
| Average Volume | 6,930 |
| Market Cap | 37.58M |
| PE | -86.33 |
| EPS | -0.09 |
| Moving Average 50 Days | 7.73 |
| Moving Average 200 Days | 8.49 |
| Change | 0.18 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,012.09 as of April 24, 2025 at a share price of $7.77. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $501.29 as of April 24, 2025 at a share price of $7.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
GlobeNewswire Inc.
Apr 22, 2025 12:00 PM GMT
Daxor Brings Advanced Blood Volume Analysis Solutions to Elite Heart and Lung Transplantation Forum Oak Ridge, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, will at
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
GlobeNewswire Inc.
Apr 17, 2025 12:00 PM GMT
WellStar Health System to Highlight New BVA-Driven Strategy That Significantly Reduces Kidney Injury Following LVAD Implantation Oak Ridge, TN, April 17, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume me
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
GlobeNewswire Inc.
Apr 15, 2025 12:00 PM GMT
Precise Volume Measurement Prior to Discharge Identifies Mortality Risk Oak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced compelling new data